Prevascularized	O
silicon	B:C0037114
membranes	O
for	O
the	O
enhancement	O
of	O
transport	O
to	O
implanted	O
medical	I:C2828363
devices	I:C2828363
Recent	O
advances	O
in	O
drug	O
delivery	I:C0085104
and	O
sensing	O
devices	O
for	O
in	O
situ	I:C0444498
applications	O
are	O
limited	O
by	O
the	O
diffusion	O
-	O
limiting	O
foreign	O
body	I:C1708386
response	I:C1708386
of	O
fibrous	O
encapsulation	O
.	O

Prevascularized	O
silicon	O
membranes	O
for	O
the	O
enhancement	O
of	O
transport	O
to	O
implanted	B:C2828363
medical	I:C2828363
devices	I:C2828363
Recent	O
advances	O
in	O
drug	O
delivery	I:C0085104
and	O
sensing	O
devices	O
for	O
in	O
situ	I:C0444498
applications	O
are	O
limited	O
by	O
the	O
diffusion	O
-	O
limiting	O
foreign	O
body	I:C1708386
response	I:C1708386
of	O
fibrous	O
encapsulation	O
.	O

Prevascularized	O
silicon	O
membranes	O
for	O
the	O
enhancement	O
of	O
transport	O
to	O
implanted	O
medical	I:C2828363
devices	I:C2828363
Recent	O
advances	O
in	O
drug	B:C0085104
delivery	I:C0085104
and	O
sensing	O
devices	O
for	O
in	O
situ	I:C0444498
applications	O
are	O
limited	O
by	O
the	O
diffusion	O
-	O
limiting	O
foreign	O
body	I:C1708386
response	I:C1708386
of	O
fibrous	O
encapsulation	O
.	O

Prevascularized	O
silicon	O
membranes	O
for	O
the	O
enhancement	O
of	O
transport	O
to	O
implanted	O
medical	I:C2828363
devices	I:C2828363
Recent	O
advances	O
in	O
drug	O
delivery	I:C0085104
and	O
sensing	O
devices	O
for	O
in	B:C0444498
situ	I:C0444498
applications	O
are	O
limited	O
by	O
the	O
diffusion	O
-	O
limiting	O
foreign	O
body	I:C1708386
response	I:C1708386
of	O
fibrous	O
encapsulation	O
.	O

Prevascularized	O
silicon	O
membranes	O
for	O
the	O
enhancement	O
of	O
transport	O
to	O
implanted	O
medical	I:C2828363
devices	I:C2828363
Recent	O
advances	O
in	O
drug	O
delivery	I:C0085104
and	O
sensing	O
devices	O
for	O
in	O
situ	I:C0444498
applications	B:C0185125
are	O
limited	O
by	O
the	O
diffusion	O
-	O
limiting	O
foreign	O
body	I:C1708386
response	I:C1708386
of	O
fibrous	O
encapsulation	O
.	O

Prevascularized	O
silicon	O
membranes	O
for	O
the	O
enhancement	O
of	O
transport	O
to	O
implanted	O
medical	I:C2828363
devices	I:C2828363
Recent	O
advances	O
in	O
drug	O
delivery	I:C0085104
and	O
sensing	O
devices	O
for	O
in	O
situ	I:C0444498
applications	O
are	O
limited	O
by	O
the	O
diffusion	O
-	O
limiting	O
foreign	B:C1708386
body	I:C1708386
response	I:C1708386
of	O
fibrous	O
encapsulation	O
.	O

Membranes	O
with	O
rectilinear	O
arrays	O
of	O
square	B:C0205120
pores	O
with	O
widths	O
ranging	O
from	O
40	O
to	O
200	O
μm	O
were	O
created	O
using	O
materials	O
(	O
50	O
μm	O
thick	O
double	O
-	O
sided	O
polished	O
silicon	I:C0037114
)	O
and	O
processes	O
(	O
photolithography	O
and	O
directed	O
reactive	O
ion	O
etching	O
)	O
common	O
in	O
the	O
manufacturing	O
of	O
microfabricated	O
sensors	O
.	O

Membranes	O
with	O
rectilinear	O
arrays	O
of	O
square	O
pores	O
with	O
widths	O
ranging	O
from	O
40	O
to	O
200	O
μm	O
were	O
created	O
using	O
materials	O
(	O
50	O
μm	O
thick	O
double	O
-	O
sided	O
polished	B:C0037114
silicon	I:C0037114
)	O
and	O
processes	O
(	O
photolithography	O
and	O
directed	O
reactive	O
ion	O
etching	O
)	O
common	O
in	O
the	O
manufacturing	O
of	O
microfabricated	O
sensors	O
.	O

Vascular	B:C1257792
endothelial	I:C1257792
cells	I:C1257792
responded	O
to	O
membrane	O
geometry	O
by	O
either	O
forming	O
vascular	O
tubes	I:C0005847
that	O
extended	O
through	O
the	O
pore	O
or	O
completely	O
filling	O
membrane	O
pores	O
after	O
4	O
days	O
in	O
culture	O
.	O

Vascular	O
endothelial	I:C1257792
cells	I:C1257792
responded	O
to	O
membrane	O
geometry	O
by	O
either	O
forming	O
vascular	B:C0005847
tubes	I:C0005847
that	O
extended	O
through	O
the	O
pore	O
or	O
completely	O
filling	O
membrane	O
pores	O
after	O
4	O
days	O
in	O
culture	O
.	O

Vascular	O
endothelial	I:C1257792
cells	I:C1257792
responded	O
to	O
membrane	O
geometry	O
by	O
either	O
forming	O
vascular	O
tubes	I:C0005847
that	O
extended	B:C0231449
through	O
the	O
pore	O
or	O
completely	O
filling	O
membrane	O
pores	O
after	O
4	O
days	O
in	O
culture	O
.	O

Although	O
tube	O
formation	O
began	O
to	O
predominate	O
overgrowth	B:C1849265
around	O
75	O
μm	O
and	O
continued	O
to	O
increase	O
at	O
even	O
larger	O
pore	O
sizes	O
,	O
tubes	O
formed	O
at	O
these	O
large	O
pore	O
sizes	O
were	O
not	O
completely	O
round	O
and	O
had	O
relatively	O
thin	O
walls	O
.	O

Although	O
tube	O
formation	O
began	O
to	O
predominate	O
overgrowth	O
around	O
75	O
μm	O
and	O
continued	O
to	O
increase	O
at	O
even	O
larger	O
pore	O
sizes	O
,	O
tubes	O
formed	O
at	O
these	O
large	O
pore	O
sizes	O
were	O
not	O
completely	O
round	B:C0332490
and	O
had	O
relatively	O
thin	O
walls	O
.	O

Although	O
tube	O
formation	O
began	O
to	O
predominate	O
overgrowth	O
around	O
75	O
μm	O
and	O
continued	O
to	O
increase	O
at	O
even	O
larger	O
pore	O
sizes	O
,	O
tubes	O
formed	O
at	O
these	O
large	O
pore	O
sizes	O
were	O
not	O
completely	O
round	O
and	O
had	O
relatively	O
thin	O
walls	B:C0442069
.	O

This	O
study	B:C2603343
lays	O
the	O
foundation	O
for	O
creating	O
a	O
prevascularized	O
port	O
that	O
can	O
be	O
used	O
to	O
reduce	O
fibrous	O
encapsulation	O
and	O
thus	O
enhance	O
diffusion	O
to	O
implanted	O
medical	I:C2828363
devices	I:C2828363
and	O
sensors	O
.	O

This	O
study	O
lays	O
the	O
foundation	O
for	O
creating	O
a	O
prevascularized	O
port	O
that	O
can	O
be	O
used	O
to	O
reduce	O
fibrous	O
encapsulation	O
and	O
thus	O
enhance	O
diffusion	O
to	O
implanted	B:C2828363
medical	I:C2828363
devices	I:C2828363
and	O
sensors	O
.	O

